StreetInsider.com News Articles

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hyliion Holdings Corp. to Contact Law Firm

Tue, 20 Oct 2026 14:56:00 -0400

Hyliion Holdings Corp. (NYSE: HYLN) shareholders should email fletcher@fmoorelaw.com

NEW YORK, Oct. 20, 2026 /PRNewswire/ -- On June 23, 2026, Pelican

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hyliion Holdings Corp. to Contact Law Firm

Tue, 20 Oct 2026 14:56:00 -0400

Hyliion Holdings Corp. (NYSE: HYLN) shareholders should email fletcher@fmoorelaw.com

NEW YORK, Oct. 20, 2026 /PRNewswire/ -- On June 23, 2026, Pelican

Hyliion’s KARNO Power Module Named to TIME’s Best Inventions of 2026

Thu, 15 Oct 2026 09:15:00 -0400

TIME recognizes Hyliion’s breakthrough KARNO Power Module for its potential to transform how electricity is generated

AUSTIN, Texas--(BUSINESS WIRE)-- Hyliion Holdings Corp. (NYSE American: HYLN), a developer of modular power plant technology, today announced that its KARNO™ Power Module has been named to TIME’s Best Inventions of 2026, an annual list recognizing groundbreaking innovations shaping the future.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015782014/en/

KARNO™ Power Module, a 200 kW linear generator

As global

Hyliion’s KARNO Power Module Named to TIME’s Best Inventions of 2026

Thu, 15 Oct 2026 09:15:00 -0400

TIME recognizes Hyliion’s breakthrough KARNO Power Module for its potential to transform how electricity is generated

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015782014/en/

KARNO™ Power Module, a 200 kW linear generator

As global

Form 8-K Hyliion Holdings Corp. For: Sep 28

Fri, 02 Oct 2026 06:01:00 -0400

si-local-file:///var/storage/secattach/20261002/27138337.html

Form 4 Hyliion Holdings Corp. For: Sep 30 Filed by: Standley Greg

Thu, 01 Oct 2026 18:00:00 -0400

si-local-file:///var/storage/secattach/20261001/27137475.html

Form 4 Hyliion Holdings Corp. For: Sep 30 Filed by: Panzer Jon

Thu, 01 Oct 2026 17:59:00 -0400

si-local-file:///var/storage/secattach/20261001/27137464.html

Form 4 Hyliion Holdings Corp. For: Sep 30 Filed by: MOOK JOSHUA T.

Thu, 01 Oct 2026 17:59:00 -0400

si-local-file:///var/storage/secattach/20261001/27137469.html

Form 4 Hyliion Holdings Corp. For: Sep 30 Filed by: Oxholm Jose Miguel

Thu, 01 Oct 2026 17:59:00 -0400

si-local-file:///var/storage/secattach/20261001/27137470.html

Form 4 Hyliion Holdings Corp. For: Sep 30 Filed by: Healy Thomas J.

Thu, 01 Oct 2026 17:58:00 -0400

si-local-file:///var/storage/secattach/20261001/27137463.html

Form 4 Hyliion Holdings Corp. For: Sep 30 Filed by: Cubbage Vincent T.

Thu, 01 Oct 2026 17:58:00 -0400

si-local-file:///var/storage/secattach/20261001/27137461.html

Craig-Hallum Starts Hyliion Holdings (HYLN) at Buy

Tue, 29 Sep 2026 09:40:58 -0400

(Updated - September 29, 2026 9:40 AM EDT)

Craig-Hallum analyst Eric Stine initiates coverage on Hyliion Holdings (NYSE: HYLN) with a Buy rating and a price target of $7.00.

The analyst comments "A power demand supercycle is underway and straining the capabilities of the electrical grid. At the same time, the availability of traditional distributed generation (DG) technologies such as large-scale natural gas turbines and diesel generators is scarce as OEM capacity is booked out several years while data center projects face growing community NIMBY concerns. With the urgency to secure power intensifying, the door is now wide open for emerging technologies

Craig-Hallum Starts Hyliion Holdings (HYLN) at Buy

Tue, 29 Sep 2026 09:40:58 -0400

(Updated - September 29, 2026 9:40 AM EDT)

Craig-Hallum analyst Eric Stine initiates coverage on Hyliion Holdings (NYSE: HYLN) with a Buy rating and a price target of $7.00.

Form 4 Hyliion Holdings Corp. For: Sep 21 Filed by: Oxholm Jose Miguel

Tue, 22 Sep 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20260922/27091489.html

Hyliion to dual list on NYSE Texas alongside primary NYSE American listing

Tue, 22 Sep 2026 08:29:04 -0400

Hyliion Holdings Corp. (NYSE American: HYLN), an Austin, Texas-based developer of modular power plant technology, announced it will dual list its common stock on NYSE Texas, a fully electronic equities exchange headquartered in Dallas that launched in 2025.

The company will maintain its primary listing on NYSE American and will trade under the same ticker symbol, HYLN, on both exchanges. The NYSE Texas listing is set to become effective Sept. 22, 2026.

Thomas Healy, founder and chief executive officer of Hyliion, cited the company's Texas roots as part of the rationale. "Texas is Hyliion's headquarters and the site of our core manufacturing

Hyliion Announces Dual Listing on NYSE Texas

Tue, 22 Sep 2026 08:27:00 -0400

Decision connects Hyliion's headquarters and manufacturing base to the capital markets fueling Texas' energy and technology growth.

AUSTIN, Texas--(BUSINESS WIRE)-- Hyliion Holdings Corp. (NYSE American: HYLN), a developer of modular power plant technology, today announced the dual listing of its common stock on NYSE Texas, a fully electronic equities exchange headquartered in Dallas, Texas that launched in 2025.

"Texas is Hyliion's headquarters and the site of our core manufacturing operations," said Thomas Healy, Founder and Chief Executive Officer of Hyliion. "This dual listing reflects the trajectory of Hyliion and puts us directly alongside the

Hyliion Announces Dual Listing on NYSE Texas

Tue, 22 Sep 2026 08:27:00 -0400

Decision connects Hyliion's headquarters and manufacturing base to the capital markets fueling Texas' energy and technology growth.

Form CERT Hyliion Holdings Corp.

Mon, 21 Sep 2026 10:59:00 -0400

si-local-file:///var/storage/secattach/20260921/27084259.html

Form 8-A12B Hyliion Holdings Corp.

Mon, 21 Sep 2026 08:07:00 -0400

si-local-file:///var/storage/secattach/20260921/27083259.html

Attention Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); Hyliion Holdings Corp. (NYSE: HYLN); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Off

Thu, 03 Sep 2026 08:47:51 -0400

PHILADELPHIA, Sept. 03, 2026 (GLOBE NEWSWIRE) --

ERASCA, INC. (NASDAQ: ERAS):

Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) breached their fiduciary duties owed to the Company and its shareholders.

What is This Investigation About? The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.

If you are a current

Attention Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); Hyliion Holdings Corp. (NYSE: HYLN); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Off

Thu, 03 Sep 2026 08:47:51 -0400

PHILADELPHIA, Sept. 03, 2026 (GLOBE NEWSWIRE) --

ERASCA, INC. (NASDAQ: ERAS):

Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) breached their fiduciary duties owed to the Company and its shareholders.

What is This Investigation About? The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.

If you are a current

Attention Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); Hyliion Holdings Corp. (NYSE: HYLN); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Off

Thu, 03 Sep 2026 08:47:51 -0400

PHILADELPHIA, Sept. 03, 2026 (GLOBE NEWSWIRE) --

ERASCA, INC. (NASDAQ: ERAS):

Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) breached their fiduciary duties owed to the Company and its shareholders.

What is This Investigation About? The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.

If you are a current

Attention Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); Hyliion Holdings Corp. (NYSE: HYLN); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Off

Thu, 03 Sep 2026 08:47:51 -0400

PHILADELPHIA, Sept. 03, 2026 (GLOBE NEWSWIRE) --

ERASCA, INC. (NASDAQ: ERAS):

Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) breached their fiduciary duties owed to the Company and its shareholders.

What is This Investigation About? The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.

If you are a current

Attention Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); Hyliion Holdings Corp. (NYSE: HYLN); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Off

Thu, 03 Sep 2026 08:47:51 -0400

PHILADELPHIA, Sept. 03, 2026 (GLOBE NEWSWIRE) --

ERASCA, INC. (NASDAQ: ERAS):

Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) breached their fiduciary duties owed to the Company and its shareholders.

What is This Investigation About? The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.

If you are a current

Attention Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); Hyliion Holdings Corp. (NYSE: HYLN); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Off

Thu, 03 Sep 2026 08:47:51 -0400

PHILADELPHIA, Sept. 03, 2026 (GLOBE NEWSWIRE) --

ERASCA, INC. (NASDAQ: ERAS):

Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) breached their fiduciary duties owed to the Company and its shareholders.

What is This Investigation About? The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.

If you are a current